Latest Tel Aviv Stock Exchange Stories

HERZLIYA, Israel, October 4, 2012 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that following the announcement from September 24, 2012, its American Depositary Receipts ("ADRs") to ordinary shares ratio has changed today to 1:20 (1 ADR represents 20 ordinary shares). Please note that the ticker Symbol will temporarily change to XTLBD for 20 trading days beginning October 4th,...

PETACH TIKVA, Israel, Oct. 4, 2012 /PRNewswire/ -- Can-Fite BioPharma (TASE: CFBI, OTC: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has listed and begun trading of its American Depository Receipts (ADRs). Shares of the ADRs began trading on October 2, 2012 on the over-the-counter (OTC) market under the symbol CANFY. The Company's ordinary shares trade on the Tel Aviv...

HERZLIYA, Israel, September 24, 2012 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. ("XTL") today announced that InterCure Ltd. ("InterCure"), which is approximately 45.4% (50.79% on a fully diluted basis) held by XTL, signed a strategic service agreement with a private company ("the Marketing Company") wholly owned by Mr. Shay Ben Yitzhak and Mr. Avner Yassur. Ben Yitzhak and Yassur, who are behind several of the most successful online marketing ventures, are now entering...

HERZLIYA, Israel, September 24, 2012 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (TASE: XTL) (OTC: XTLBY) (the "Company"), a biopharmaceutical development company, announced today that it has approved a change in the ratio of its American Depositary Receipts ("ADRs") to ordinary shares in order to facilitate the Company's qualification for listing on the NASDAQ Capital Market. XTL and its advisors believe that following the ADR ratio change, the $4.00 ADR minimum...

ALLEGAN, Mich., Sept. 18, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Executive Vice President and Chief Financial Officer Judy Brown will present at the UBS Global Life Sciences Conference on Wednesday, September 19, 2012 at the Grand Hyatt Hotel in New York, NY at 3:00 PM EST. From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality,...

HAIFA, Israel, September 13, 2012 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) ("Oil Refineries Ltd" or the "Company") Israel's largest integrated refining and petrochemical group, announced its notice in accordance with the 2000 Companies Regulations (Announcement and notice of a general shareholder meeting and a shareholder class meeting in a public company), in regard to the convening of an Annual and Special Meeting of the Company's shareholders on Monday, September...

AIRPORT CITY, Israel, August 30, 2012 /PRNewswire/ -- - 21% Revenue Growth compared with Q2 last year - to NIS 1.6 billion - Profit in the quarter grew 46% compared with Q2 of last year after neutralizing the gain from ADO acquisition Ofer Kotler, CEO of Shikun & Binui: "The Group's diverse growth engines make it possible to expand our volume of activity despite the global economic situation and...

TEL AVIV, Israel, August 29, 2012 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG, OTCQX: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results for the three and six month period ended June 30, 2012. The full financial statements will be available in English on Delek Group's website at: http://www.delek-group.com. First Six Months 2012 Highlights - Group operating profit of NIS 1.3 billion, an increase of 5% compared with...

REHOVOT, Israel, August 29, 2012 /PRNewswire/ -- Sapiens International Corporation N.V. [http://www.sapiens.com ] (NASDAQ and TASE: SPNS), a provider of innovative insurance software solutions and a member of the Formula Group (NASDAQ: FORTY and TASE: FORT), will present to the investment community at the following upcoming three investor conferences in the US: The Wall Street Forum's Conference Date: Friday, September 7th Presentation:...

TEL-AVIV, Israel, August 17, 2012 /PRNewswire/ -- In the news release, "ICL Appoints Stefan Borgas as New President & CEO" issued on 17 Aug 2012 07:49 GMT, by ICL - Israel Chemicals Ltd OTC-PINK:ISCHF over PR Newswire, we are advised by a representative of the company that Nir Gilad, mentioned in the third sub-headline, is Chairman of ICL and not Israel Corp. Complete, corrected release follows: - Former CEO of Swiss Chemicals Manufacturer, Lonza,...